 NEW YORK and RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2020 GLOBE NEWSWIRE -- Sio Gene Therapies, Inc. NASDAQ: SIOX, a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, today provided financial results for its second fiscal quarter ended September 30, 2020. 